NFATc2IP activators are specialized chemical agents designed to enhance the activity of NFATc2IP, also known as Nuclear Factor of Activated T-cells, cytoplasmic 2 Interacting Protein. NFATc2IP is known to be involved in the regulation of gene transcription by modulating the function of NFATc2, a member of the NFAT (nuclear factor of activated T-cells) family that plays a role in the transcription of genes following the influx of calcium into cells. Activators of NFATc2IP could, therefore, affect the NFATc2-mediated transcriptional pathways. The activation of NFATc2IP could be achieved by increasing its expression levels, stabilizing the protein, or enhancing its interaction with NFATc2 or other components of the transcriptional machinery. These chemical activators might bind to NFATc2IP and induce conformational changes that facilitate its nuclear localization or augment its affinity for NFATc2, thereby promoting the transcription of target genes.
The design and development of NFATc2IP activators require a detailed understanding of the protein's structure and interactions within the cell. This is typically achieved through robust techniques such as X-ray crystallography, cryo-electron microscopy, or nuclear magnetic resonance (NMR) spectroscopy, which provide insight into the three-dimensional conformation of NFATc2IP and the potential binding sites for activators. With this structural information, researchers can utilize computational tools to model the interaction between NFATc2IP and small molecules, predicting those that might enhance its activity. Following in silico analyses, promising compounds are synthesized and subjected to a battery of biochemical assays to test their ability to bind NFATc2IP and facilitate its function. These assays can measure various parameters such as protein stability, binding affinity, and the ability to interact with NFATc2 or other regulatory proteins.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol, known for its ability to stimulate histone acetylation, could potentially upregulate NFATC2IP expression by promoting a more transcriptionally active state at the IL4 locus. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin, recognized for enhancing Th2 responses, might indirectly stimulate NFATC2IP expression, given the protein's prominent role in Th2 cell-mediated cytokine gene transcription. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
As a histone deacetylase inhibitor, sodium butyrate could potentially foster an environment conducive to NFATC2IP expression by maintaining histone acetylation at the IL4 locus. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
Valproic acid, another histone deacetylase inhibitor, could hypothetically upregulate NFATC2IP expression by preserving an active transcriptional state at the IL4 locus. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine may indirectly stimulate NFATC2IP expression by reducing DNA methylation levels, thereby promoting a more open chromatin structure and facilitating gene expression. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
By acting as a DNA methyltransferase inhibitor, decitabine might foster NFATC2IP expression by reducing DNA methylation and promoting a more transcriptionally active chromatin state. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
As a histone deacetylase inhibitor, trichostatin A could theoretically stimulate NFATC2IP expression by ensuring a transcriptionally active state at the IL4 locus. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Suberoylanilide Hydroxamic Acid, another histone deacetylase inhibitor, could potentially increase NFATC2IP expression by preserving an active transcriptional state at the IL4 locus. | ||||||
Romidepsin | 128517-07-7 | sc-364603 sc-364603A | 1 mg 5 mg | $218.00 $634.00 | 1 | |
Romidepsin's role as a histone deacetylase inhibitor suggests that it might promote NFATC2IP expression by aiding in maintaining a transcriptionally active state at the IL4 locus. | ||||||
Panobinostat | 404950-80-7 | sc-208148 | 10 mg | $200.00 | 9 | |
Panobinostat, as a histone deacetylase inhibitor, could potentially foster NFATC2IP expression by preserving an active transcriptional state at the IL4 locus. | ||||||